CHEK2 and non-Hodgkin lymphoma: We found germline mutations altering CHK2 protein sequence to be associated not only with an increased risk of NHL development, but also with unfavorable NHL survival in mutation carriers (NHL HRPFS = 2.1; P = 0.02, Fig 2A).